Role for transcription factor TFII-I in the suppression of SSeCKS/Gravin/Akap12 transcription by Src

被引:14
|
作者
Bu, Yahao [2 ]
Gao, Lingqiu [1 ]
Gelman, Irwin H. [1 ]
机构
[1] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA
[2] Kinex Pharmaceut LLC, Buffalo, NY USA
关键词
Src; SSeCKS/; Gravin/; AKAP12; Sp1; Sp3; USF1; HDAC1; TFII; I; Gtf2i; mass spectrometry; V-SRC; GENE-EXPRESSION; TYROSINE KINASE; DOWN-REGULATION; BREAST-CANCER; QR1; GENE; ACTIVATION; PROMOTER; SP1; FAMILY;
D O I
10.1002/ijc.25524
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The SSeCKS/Gravin/AKAP12 gene, encoding a kinase scaffolding protein with metastasis- suppressing activity, is transcriptionally downregulated in Src- transformed cells through the recruitment of HDAC1 to a Src- responsive proximal promoter site charged with Sp1, Sp3 and USF1. However, the ectopic expression of these proteins formed a suppressive complex in Src- transformed but not in parental NIH3T3 cells, suggesting the involvement of additional repressor factors. Transcription factor II-I (TFII-I) [ general transcription factor 2i (Gtf2i)] was identified by mass spectrometry as being associated with the SSeCKS promoter complex in NIH3T3/Src cells, and moreover, the Src- induced tyrosine phosphorylation of TFII-I significantly increased its binding to the SSeCKS proximal promoter. siRNA- mediated knockdown of TFII-I or the expression of TFII- I Y248/249F caused the derepression of SSeCKS in NIH3T3/Src cells. Taken with previous data showing that the tyrosine phosphorylation of TFII- I facilitates its nuclear translocation, these data suggest that Src- family kinase- mediated phosphorylation converts a portion of TFII- I into a transcriptional repressor. Cancer Genetics
引用
收藏
页码:1836 / 1842
页数:7
相关论文
共 50 条
  • [11] SSeCKS/Gravin/AKAP12 Suppresses metastasis through tumor- and microenvironment-specific pathways
    Akakura, Shin
    Su, Bing
    Nochajski, Peter
    Foster, Barbara
    Huang, Changhui
    Nelson, Peter J.
    Gelman, Irwin H.
    CLINICAL & EXPERIMENTAL METASTASIS, 2009, 26 (07) : 864 - 864
  • [12] DIRECT ROLE FOR MYC IN TRANSCRIPTION INITIATION MEDIATED BY INTERACTIONS WITH TFII-I
    ROY, AL
    CARRUTHERS, C
    GUTJAHR, T
    ROEDER, RG
    NATURE, 1993, 365 (6444) : 359 - 361
  • [13] AN ALTERNATIVE PATHWAY FOR TRANSCRIPTION INITIATION INVOLVING TFII-I
    ROY, AL
    MALIK, S
    MEISTERERNST, M
    ROEDER, RG
    NATURE, 1993, 365 (6444) : 355 - 359
  • [14] Transcription factor TFII-I fine tunes innate properties of B lymphocytes
    Kaila, Mary
    Singh, Amit
    De, Supriyo
    Mazan-Mamczarz, Krystyna
    Sen, Ranjan
    Roy, Ananda
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [15] The Transcription Factor TFII-I Promotes DNA Translesion Synthesis and Genomic Stability
    Fattah, Farjana J.
    Hara, Kodai
    Fattah, Kazi R.
    Yang, Chenyi
    Wu, Nan
    Warrington, Ross
    Chen, David J.
    Zhou, Pengbo
    Boothman, David A.
    Yu, Hongtao
    PLOS GENETICS, 2014, 10 (06):
  • [16] Histone deacetylase 3 binds to and regulates the multifunctional transcription factor TFII-I
    Wen, YD
    Cress, WD
    Roy, AL
    Seto, E
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) : 1841 - 1847
  • [17] Induction of immunoglobulin heavy-chain transcription through the transcription factor Bright requires TFII-I
    Rajaiya, Jaya
    Nixon, Jamee C.
    Ayers, Neil
    Desgranges, Zana P.
    Roy, Ananda L.
    Webb, Carol F.
    MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (12) : 4758 - 4768
  • [18] The Role of Transcription Factor Tfii-I/GTF2I in the Response to Cellular Stress in Hematopoietic Cells
    Fan, Xiucheng
    BLOOD, 2014, 124 (21)
  • [19] Transcription factor TFII-I fine tunes innate properties of B lymphocytes
    Singh, Amit
    Kaileh, Mary
    De, Supriyo
    Mazan-Mamczarz, Krystyna
    Bayarsaihan, Dashzeveg
    Sen, Ranjan
    Roy, Ananda L.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [20] Multifunctional transcription factor TFII-I is an activator of BRCA1 function
    M Tanikawa
    O Wada-Hiraike
    S Nakagawa
    A Shirane
    H Hiraike
    S Koyama
    Y Miyamoto
    K Sone
    T Tsuruga
    K Nagasaka
    Y Matsumoto
    Y Ikeda
    K Shoji
    K Oda
    H Fukuhara
    K Nakagawa
    S Kato
    T Yano
    Y Taketani
    British Journal of Cancer, 2011, 104 : 1349 - 1355